Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

被引:573
作者
Nakayama, M
Abiru, N
Moriyama, H
Babaya, N
Liu, E
Miao, DM
Yu, LP
Wegmann, DR
Hutton, JC
Elliott, JF
Eisenbarth, GS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528501, Japan
[3] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan
[4] Univ Alberta, Edmonton, AB T6G 2S2, Canada
关键词
D O I
10.1038/nature03523
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A fundamental question about the pathogenesis of spontaneous autoimmune diabetes is whether there are primary autoantigens. For type 1 diabetes it is clear that multiple islet molecules are the target of autoimmunity in man and animal models(1,2). It is not clear whether any of the target molecules are essential for the destruction of islet beta cells. Here we show that the proinsulin/ insulin molecules have a sequence that is a primary target of the autoimmunity that causes diabetes of the non-obese diabetic ( NOD) mouse. We created insulin 1 and insulin 2 gene knockouts combined with a mutated proinsulin transgene ( in which residue 16 on the B chain was changed to alanine) in NOD mice. This mutation abrogated the T-cell stimulation of a series of the major insulin autoreactive NOD T-cell clones(3). Female mice with only the altered insulin did not develop insulin autoantibodies, insulitis or autoimmune diabetes, in contrast with mice containing at least one copy of the native insulin gene. We suggest that proinsulin is a primary autoantigen of the NOD mouse, and speculate that organ-restricted autoimmune disorders with marked major histocompatibility complex (MHC) restriction of disease are likely to have specific primary autoantigens.
引用
收藏
页码:220 / 223
页数:4
相关论文
共 28 条
  • [1] Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse
    Abiru, N
    Wegmann, D
    Kawasaki, E
    Gottlieb, P
    Simone, E
    Eisenbarth, GS
    [J]. JOURNAL OF AUTOIMMUNITY, 2000, 14 (03) : 231 - 237
  • [2] A role of Hsp60 in autoimmune diabetes: Analysis in a transgenic model
    Birk, OS
    Douek, DC
    Elias, D
    Takacs, K
    Dewchand, H
    Gur, SL
    Walker, MD
    vanderZee, R
    Cohen, IR
    Altmann, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) : 1032 - 1037
  • [3] Therapeutic vaccination using CD4+ CD25+ antigen-specific regulatory T cells
    Bluestone, JA
    Tang, QZ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 : 14622 - 14626
  • [4] Chatenoud L, 1997, J IMMUNOL, V158, P2947
  • [5] DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
  • [6] During the early prediabetic period in NOD mice, the pathogenic CD8+ T-cell population comprises multiple antigenic specificities
    DiLorenzo, TP
    Lieberman, SM
    Takaki, T
    Honda, S
    Chapman, HD
    Santamaria, P
    Serreze, DV
    Nathenson, SG
    [J]. CLINICAL IMMUNOLOGY, 2002, 105 (03) : 332 - 341
  • [7] Phenotypic alterations in insulin-deficient mutant mice
    Duvillie, B
    Cordonnier, N
    Deltour, L
    DandoyDron, F
    Itier, JM
    Monthioux, E
    Jami, J
    Joshi, RL
    Bucchini, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 5137 - 5140
  • [8] Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats
    Ellerman, KE
    Like, AA
    [J]. DIABETOLOGIA, 2000, 43 (07) : 890 - 898
  • [9] Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
    French, MB
    Allison, J
    Cram, DS
    Thomas, HE
    DempseyCollier, M
    Silva, A
    Georgiou, HM
    Kay, TW
    Harrison, LC
    Lew, AM
    [J]. DIABETES, 1997, 46 (01) : 34 - 39
  • [10] Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes
    Jaeckel, E
    Lipes, MA
    von Boehmer, H
    [J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 1028 - 1035